Concepedia

Maha Maglinao

MM

8

Publications

497

Citations

8

H-Index

2010

Active since

Affiliations

Max Planck Institute of Colloids and Interfaces(Current)

Freie Universität Berlin

Moderna Therapeutics (United States)

Duke Medical Center

Max Planck Society

Maha Maglinao is an author at Max Planck Institute of Colloids and Interfaces specializing in medicine, glycobiology, and biomolecular engineering.

Top concepts

MedicineGlycobiologyImmunologyBiomolecular EngineeringPolymersVirologyBiopolymersEngineeringRna BiologyVaccination

Publications per year

2010–2022

8

Publications

8

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization

Nicole A. Doria‐Rose, Xiaoying Shen, Stephen D. Schmidt et al. · 2021 · 129 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +15

Hexameric Supramolecular Scaffold Orients Carbohydrates To Sense Bacteria

Dan Grünstein, Maha Maglinao, Raghavendra Kikkeri et al. · Journal of the American Chemical Society · 2011 · 85 citations

Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting

Gonçalo J. L. Bernardes, Raghavendra Kikkeri, Maha Maglinao et al. · Organic & Biomolecular Chemistry · 2010 · 79 citations

Nanotherapeutics, Terminal D-galnac Residue, Glycobiology +22

A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation

Maha Maglinao, Magdalena Eriksson, Mark K. Schlegel et al. · Journal of Controlled Release · 2013 · 70 citations

G Protein-coupled Receptor, Glycobiology, Immunology +10

The C-Type Lectin Receptor DCIR Is Crucial for the Development of Experimental Cerebral Malaria

Maha Maglinao, Robert Klopfleisch, Peter H. Seeberger et al. · The Journal of Immunology · 2013 · 46 citations

Rows per page

1–5 of 8